Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline.

导出 OA

翻译打印收藏纠错

第一作者： Guangguo,Tan

第一单位： School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China.

作者： Guangguo,Tan ^[1] ; Bingbing,Zhao ^[2] ; Yanqing,Li ^[2] ; Xi,Liu ^[2] ; Zhilan,Zou ^[2] ; Jun,Wan ^[2] ; Ye,Yao ^[2] ; Hong,Xiong ^[2] ; Yanyu,Wang ^[2]

作者单位： School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, China. ^[1] Department of Hematology, The Central Hospital of Xuhui District, Shanghai, 20031, China. ^[2]

关键词 acute myeloid leukemia chemosensitivity liquid chromatography-mass spectrometry metabolomics pharmacometabolomics

DOI 10.18632/oncotarget.20733

PMID 29179468

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交